Incy just had Rux approval and it's up a dollar or so. It has been taken to the woodshed in the last few months. According to Yahoo, lowest analyst has it @ $17, mean/median $23, highest @ $27.
Point being it's not a great market for biotech (including Ariad) right now.
EDIT: Change that from not a great market to a lousy market :0(
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.